{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T11:40:03Z","timestamp":1739878803409,"version":"3.37.3"},"reference-count":22,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2010,2,12]],"date-time":"2010-02-12T00:00:00Z","timestamp":1265932800000},"content-version":"vor","delay-in-days":11,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ther Apher Dial"],"published-print":{"date-parts":[[2010,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>ABO\u2010incompatible (ABO\u2010I) liver transplantation has been performed essentially in patients with acute liver failure awaiting an urgent liver transplantation. Early results with ABO\u2010I liver transplantation were disappointing with a very low graft survival rate (20\u201350%). The main risk is the occurrence of severe humoral and cellular rejection, vascular thrombosis, and biliary complications. In order to avoid humoral rejection and improve graft survival, total plasma exchange in combination with an intense immunosuppressive regimen has been proposed to decrease hemagglutinin titers in ABO\u2010I liver grafts. In some centers, this regimen was associated with splenectomy, phototherapy, and portal or arterial intrahepatic infusion therapy; however, as these patients are at high risk of sepsis, a selective approach using antigen\u2010specific immunoadsorption with immunoadsorbent columns has been successfully proposed for ABO\u2010I living donor kidney transplantation. Few cases have been reported following liver transplantation. We report our recent experience with three adult patients (two patients with acute liver failure, and one with severe cirrhosis and hepatic encephalopathy) transplanted in an emergency situation with an ABO\u2010I liver graft and managed with the use of GlycoSorb ABO immunoadsorbent columns and a quadruple immunosuppressive regimen with preservation of the spleen. Eight sessions were performed in the three patients. Antigen\u2010specific immunoadsorption greatly lowered the anti\u2010A hemagglutinin titers. None of the three patients developed acute humoral or cellular rejection. Two patients are alive at 1.5 and 3\u2003years follow\u2010up with a normally functioning graft. The third patient died with a functioning graft, one month after the transplantation, from septic complications.<\/jats:p>","DOI":"10.1111\/j.1744-9987.2009.00792.x","type":"journal-article","created":{"date-parts":[[2010,2,12]],"date-time":"2010-02-12T08:34:31Z","timestamp":1265963671000},"page":"116-123","source":"Crossref","is-referenced-by-count":12,"title":["Successful Long\u2010term Outcome of ABO\u2010incompatible Liver Transplantation Using Antigen\u2010specific Immunoadsorption Columns"],"prefix":"10.1111","volume":"14","author":[{"given":"Faouzi","family":"Saliba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Icha\u00ef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houssam","family":"Habbouchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Antonini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myl\u00e8ne","family":"Sebagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9","family":"Adam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Castaing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,2,12]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2003.00000"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)92082-S"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199504270-00009"},{"key":"e_1_2_5_5_2","first-page":"489","article-title":"Antibody\u2010mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers","volume":"132","author":"Demetris AJ","year":"1988","journal-title":"Am J Pathol"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20002"},{"key":"e_1_2_5_7_2","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1399-0012.1987.tb00678.x","article-title":"Hyperacute rejection of a human orthotopic liver allograft in a presensitized recipient","volume":"1","author":"Hanto DW","year":"1987","journal-title":"Clin Transplant"},{"key":"e_1_2_5_8_2","first-page":"2567","article-title":"Expression of blood group antigen (A,B,H, Le(a), Le(b)) on liver allografts","volume":"24","author":"Hayashi S","year":"1992","journal-title":"Transplant Proc"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199504150-00011"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1526-0968.2002.00460.x"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2003.50011"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1594.2000.06490.x"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-1345(00)01589-X"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20727"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000078622.43689.D4"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000149337.40911.E4"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2004.12.114"},{"key":"e_1_2_5_18_2","first-page":"599","article-title":"Liver transplantation in Japan: registry by the Japanese Liver Transplantation Society","volume":"41","author":"The Japanese Liver Transplantation Society","year":"2006","journal-title":"Isyoku"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000110295.88926.5C"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20760"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0b013e31819f2024"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1053\/jlts.2000.6448"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1432-2277.2007.00492.x"}],"container-title":["Therapeutic Apheresis and Dialysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1744-9987.2009.00792.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1744-9987.2009.00792.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T11:02:38Z","timestamp":1739876558000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1744-9987.2009.00792.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["10.1111\/j.1744-9987.2009.00792.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1744-9987.2009.00792.x","archive":["Portico"],"relation":{},"ISSN":["1744-9979","1744-9987"],"issn-type":[{"type":"print","value":"1744-9979"},{"type":"electronic","value":"1744-9987"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}